Ophthalmic compositions for treating ocular hypertension

Details for Australian Patent Application No. 2004226479 (hide)

Owner Merck & Co., Inc. Evotec OAI

Inventors Parsons, William H.; Meinke, Peter T.; Stibbard, John; Price, Stephen; Garcia, Maria L.; Boyd, Edward Andrew; Fisher, Michael H.; Kaczorowski, Gregory J.

Agent Spruson & Ferguson

Pub. Number AU-A-2004226479

PCT Pub. Number WO2004/087051

Priority 60/458,103 27.03.03 US

Filing date 24 March 2004

Wipo publication date 14 October 2004

International Classifications

A61K 031/404

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087051 Priority application(s): WO2004/087051

22 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226482-Rigid air ducting for respirator hoods and helmets

2004226467-Reduction of hair growth